Life Sciences Times, Author at Life Sciences Times

Strand Therapeutics Names Dr. Jason J. Luke as Chief Medical Officer

August 21, 2025

Sensory Cloud Reports Positive Phase 2a Results for SC0023 in Patients With Refractory Chronic Cough

August 20, 2025

knownwell Expands in Greater Boston, Opens Second Clinic in Woburn

August 19, 2025

THIS WEEK'S STORIES

Sensory Cloud Reports Positive Phase 2a Results for SC0023 in Patients With Refractory Chronic Cough

August 20, 2025

Method AI Secures $20 Million to Advance Surgical Navigation Platform for Cancer Procedures

August 22, 2025

Abcuro Names George Eldridge Chief Financial Officer

August 18, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Life Sciences Times

TOP AUTHORS

Most Read

Modivcare Faces Nasdaq Delisting After Chapter 11 Bankruptcy Filing

Method AI Secures $20 Million to Advance Surgical Navigation Platform for Cancer Procedures

SMSbiotech Launches First-in-Human Clinical Trial for COPD Stem Cell Therapy

Geneoscopy Scores Legal Win as Exact Sciences Drops Injunction Bid Against ColoSense

EDITOR PICKS

Strand Therapeutics Names Dr. Jason J. Luke as Chief Medical Officer

Sensory Cloud Reports Positive Phase 2a Results for SC0023 in Patients With Refractory Chronic Cough

knownwell Expands in Greater Boston, Opens Second Clinic in Woburn

THIS WEEK'S STORIES

Sensory Cloud Reports Positive Phase 2a Results for SC0023 in Patients With Refractory Chronic Cough

Method AI Secures $20 Million to Advance Surgical Navigation Platform for Cancer Procedures

Abcuro Names George Eldridge Chief Financial Officer

POPULAR CATEGORY

ABOUT US

FOLLOW US